Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Episode 33 September 20, 2023 00:26:33
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals
Few & Far Between: How Biotech Gets Built
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Sep 20 2023 | 00:26:33

/

Show Notes

View Full Transcript

Episode Transcript

"Having come from the clinical trial side, I then went to the management side. So, I understood all the problems that occur or arise when a clinical trial is being conducted - knowing what to watch out for, why the protocol is written the way it is. So that was an immense help." - Dr. Diana Sims-Silbermann Biorasi CEO, Chris O'Brien, welcomes Dr. Diana Sims-Silbermann to the latest episode of the Few & Far Between podcast. In her previous roles as a clinician and Senior Trial Manager for Janssen Pharmaceuticals, Dr. Sims-Silbermann has remained an inquisitive observer and skilled facilitator for clinical studies in Europe, with a keen understanding of regulatory requirements and patient centricity.

Other Episodes

Episode 19

April 20, 2022 00:36:19
Episode Cover

Episode 19: Leslie Michelson, Founder and CEO, Private Health Management

How do you obtain the best possible patient care available? On this week's Few & Far Between podcast, host Chris O'Brien welcomes patient advocacy...

Listen

Episode 42

July 16, 2024 00:36:14
Episode Cover

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...

Listen

Episode 71

May 12, 2026 00:43:24
Episode Cover

Episode 71: Chris O'Brien, Former ⁨Biorasi⁩ CEO and Current CEO of ⁨Rancho Biosciences

Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences...

Listen